AETracker will also manage off-label, product complaints, overdose and drug abuse related comments on branded and unbranded Facebook pages.
BRIDGEWATER, N.J., Nov. 27, 2012 /PRNewswire-iReach/ -- Semantelli Corporation announced today that a $400 million OTC brand has deployed Semantelli's AETracker® to detect and manage adverse events, drug overdose and product complaints reported by consumers in brand sponsored Facebook pages, enabling it to continue its marketing plan with confidence in remaining compliant in its dialogue with customers.
(Photo: http://photos.prnewswire.com/prnh/20121127/CG19358)
AETracker™ is the healthcare industry's only software solution that detects and manages Adverse Events in company sponsored social media and mobile applications 24/7.
"This particular OTC brand's decision to monitor patient safety 24/7 in their Facebook pages demonstrates employing a social media strategy is possible within the healthcare segment while assuring compliance. The brand has had tremendous sales success on Facebook. Ensuring compliance in these medium is another step in the right direction, and shows the brand's responsibility towards safety", said Siva Nadarajah, CEO of Semantelli Corp.
According to Consumer Healthcare Products Association (CHPA), 240 million people in the U.S. currently use OTC medicines. The availability of OTC medicines provides $102 billion in value to the U.S. healthcare system annually. A Semantelli study found that Facebook has become the primary customer relations hub for many of the OTC brands and some brand Facebook pages generate close to 40,000 interactions a week.
In August of 2011, Semantelli launched AETracker to help healthcare companies monitor and manage adverse events reported on company owned Facebook pages. Semantelli later released a version of AETracker to monitor mobile apps and other sponsored social outlets. Currently AETracker has been deployed by some of the top 10 pharma, OTC and other healthcare companies.
About AETracker™
Powered by patent pending technology and 24x7 pharmacovigilance support, AETracker helps pharmaceutical companies monitor and respond to potential adverse events, product complaints, misinformation and off-label comments on company sponsored social media and mobile applications.
About Semantelli
Semantelli is the leader in social listening solutions for the global life sciences industry. Companies use Semantelli's compliance sensitive solutions to monitor social media and other digital assets to find previously unknown early warnings, threats, and opportunities. Semantelli customers have found immediate ROI, ranging from spotting early compliance warnings, new trends, micro-targeted promotions to engaging customers who have shown signs of switching to competitor brands.
Semantelli is a privately-held company headquartered in Bridgewater, NJ.
For more information go to: http://www.semantelli.com/pharma/aetracker
Contacts:
Semantelli Corporation
991, US Hwy 22, Suite 200
Bridgewater, NJ 08807
1-866-277-9057
[email protected]
Media Contact: John Jason Semantelli Corp., 1-866-277-9057, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Semantelli Corp.